TABOXEA 25 MG TBL PRO 60
Rychlý přehled
| Dosage form | Tablets with prolonged release |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 343,30 Kč. Maximální cena: 524,43 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Tapentadol-tartarát (41,9525 mg), tapentadol (25 mg), povidon k 30, mikrokrystalická celulosa, hypromelosa 2506/15000, koloidní bezvodý oxid křemičitý, magnesium-stearát, polydextrosa, oxid titaničitý, maltodextrin, tri… |
| Dostupnost / výpadek | The latest report from the manufacturer is from 18. 11. 2025. Výroba je oficiálně zahájena od 1. 12. 2025. |
| Kód SÚKL | 0268985 |
What is the maximum co-payment for TABOXEA?
If the insurance company contributes, the maximum co-payment is 343,30 Kč. The maximum pharmacy price is 524,43 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price. If the physician marks increased reimbursement on the prescription, the maximum co-payment is 0,00 Kč.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does TABOXEA have a counted co-payment set?
Yes, the medicine has a counted co-payment of 296,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
181,13 Kč.
Does the insurance company pay a higher amount in some cases?
Yes, increased reimbursement exists. A physician with the required specialization may, under strictly defined conditions, set a second reimbursement of 542,00 Kč.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe TABOXEA?
Prescription is not conditional on a medical specialization.
What is the composition of TABOXEA?
Tapentadol-tartarát (41,9525 mg), tapentadol (25 mg), povidon k 30, mikrokrystalická celulosa, hypromelosa 2506/15000, koloidní bezvodý oxid křemičitý, magnesium-stearát, polydextrosa, oxid titaničitý, maltodextrin, triacylglyceroly se středním řetězcem, žlutý oxid železitý, černý oxid železitý, červený oxid železitý. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to TABOXEA?
The medicine belongs to ATC group N02AX06 – . Medicines with the same active substance can be found here.
Who manufactures TABOXEA?
GL Pharma GmbH, Lannach (A)
Is the medicine in shortage?
The latest report from the manufacturer is from 18. 11. 2025. Production has been officially started as of 1. 12. 2025.
What is the unique code for TABOXEA?
The medicine has code 0268985. Code details can be found here.
How many packs of TABOXEA were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of TABOXEA were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026